A world-first scabies control program has drastically reduced cases of the highly contagious parasitic skin disease in Solomon Islands and Fiji, according to a new study.
National scabies control program drastically reduces parasitic skin disease in Pacific nations
An overactive immune response in the brain may play a role in Dravet Syndrome, a rare and severe genetic epilepsy that typically begins in infancy, according to Weill Cornell Medicine researchers.
Overactive brain immune response linked to rare, severe genetic epilepsy
Researchers have developed a new artificial intelligence-based method that could significantly improve the detection and classification of brain tumors from MRI scans, achieving higher accuracy than conventional diagnostic systems.
New AI-based method could improve detection and classification of brain tumors from MRI scans
A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD).
Oral semaglutide reduces heavy drinking in adults with alcohol use disorder
Women who reach menopause before age 40 face a meaningfully higher risk of developing high blood pressure than those who go through menopause after age 45, according to a new study of more than 107,000 women.
Premature menopause linked to higher risk of developing hypertension
Cardiovascular disease is becoming increasingly common in young people aged 20 to 29, according to the World Health Organization, due to the rise in metabolic conditions such as obesity, hypertension, hyperlipidemia, and diabetes among young populations worldwide.
AI model accurately predicts how effectively the heart pumps blood
A gene editing tool designed to precisely rewrite the gene that causes Huntington's disease reduced toxic protein fragments and symptoms associated with the disease in mice, researchers at the University of Illinois Urbana-Champaign report.
New gene editing tool reduces Huntington's symptoms in mice
Nearly 23 million Americans with blood pressure 130/80 mm Hg or higher may be eligible for blood-pressure-lowering medications based on the 2025 American Heart Association/American College of Cardiology guideline, according to new, independent research published today in the Journal of the American Heart Association, an open access, peer-reviewed scientific journal of the American Heart Association.
New study reveals massive gap in American blood pressure care